- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: tiotropium bromide inhalation powder HandiHaler
Total 550 results
-
Milton S. Hershey Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
AlgiPharma ASImperial College London; Cystic Fibrosis Foundation; University Hospital of Cologne and other collaboratorsWithdrawnCystic FibrosisGermany
-
Orion Corporation, Orion PharmaCompletedHealthy SubjectsFinland
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveItaly
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveGermany
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Boehringer IngelheimCompleted
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
University of CreteCompletedChronic Obstructive Pulmonary Disease
-
AstraZenecaCompletedAsthma | Chronic Obstructive Pulmonary Disease COPDUnited States
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic Obstructive
-
GlaxoSmithKlineCompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic Obstructive
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveCanada, Germany, United States, Australia
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveCanada
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Czech Republic, Germany, Hungary, Poland
-
Boehringer IngelheimPfizerCompletedAsthmaUnited States, Belgium, Finland, Germany, Korea, Republic of, Latvia, Lithuania, Malaysia, Netherlands, Philippines, Ukraine
-
Boehringer IngelheimPfizerCompletedAsthmaGermany, Hungary, Latvia, Lithuania, Russian Federation, Ukraine
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic Obstructive
-
Mannkind CorporationCompletedDiabetes Mellitus, Type 2 | Healthy MalesNetherlands
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic Obstructive | AsthmaNetherlands, Germany, Belgium, France, Canada, Italy, South Africa, Denmark
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic Obstructive
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Canada
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveBelgium, Netherlands
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Puerto Rico
-
University of SaskatchewanCompleted
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease | COPDGermany
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructivePortugal
-
Mannkind CorporationCompletedHealthy VolunteersUnited States
-
Orion Corporation, Orion PharmaCompletedHealthy VolunteersFinland
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseAustralia, United States, New Zealand
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveJapan
-
University Hospital, GhentBoehringer IngelheimCompleted
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Germany, Japan, Romania, Russian Federation, Ukraine, Argentina, Poland, Czechia
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Germany, Japan, Russian Federation, Chile, Poland, Mexico, Estonia, Korea, Republic of, Philippines
-
Huashan HospitalUnknown
-
Boehringer IngelheimPfizerCompletedPulmonary Disease, Chronic ObstructiveAustria, Belgium, Bulgaria, Czech Republic, Denmark, Finland, France, Germany, Hungary, Israel, Italy, Latvia, Lithuania, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Slovakia, Slovenia, Spain, Turkey, Ukraine, United...
-
Boehringer IngelheimCompleted
-
Mannkind CorporationCompletedDiabetes Mellitus, Type 2Netherlands
-
NovartisCompletedChronic Obstructive Pulmonary DiseaseUnited States, Argentina, Germany, Russian Federation, France, Israel, Korea, Republic of, Italy, Poland, Chile, Mexico, Peru, Canada, Hungary, Netherlands, New Zealand
-
Novartis PharmaceuticalsWithdrawnChronic Obstructive Pulmonary Disease (COPD)
-
GlaxoSmithKlineCompletedAsthmaUnited States, Germany, Japan, Romania, Russian Federation, Poland
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveGreece
-
Boehringer IngelheimPfizerCompletedPulmonary Disease, Chronic ObstructivePoland